| Trial of Antiseptic Irrigation for Pleural Infection (NCT05546762) | Alexandria University | 2022-09-19 |
| Neoadjuvant Tislelizumab With Afatinib for Resectable Head and Neck Squamous Cell Carcinoma (NCT05517330) | West China Hospital | 2022-09-19 |
| Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab (NCT05363631) | Mohammed Milhem | 2022-09-19 |
| A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma (NCT05309421) | Evaxion Biotech A/S | 2022-09-19 |
| Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Aureus (NCT05889351) | Pharma Holdings AS | 2022-09-19 |
| A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis (NCT05242484) | Janssen Research & Development, LLC | 2022-09-19 |
| 64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE) (NCT05407311) | Clarity Pharmaceuticals Ltd | 2022-09-19 |
| Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients (NCT03905109) | Abivax S.A. | 2022-09-19 |
| Neural Correlates of Acute Pain Dynamics (NCT05669924) | Northwestern University | 2022-09-19 |
| Doxycycline in Cutaneous Schwannoma (NF2) (NCT05521048) | Massachusetts Eye and Ear Infirmary | 2022-09-19 |
| Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage Trial (NCT05331131) | Northwell Health | 2022-09-19 |
| Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study (NCT05284097) | London School of Hygiene and Tropical Medicine | 2022-09-19 |
| Venetoclax, Rituximab and Ibrutinib in TN Patients With CLL Undetectable Minimal Residual Disease (uMRD) in Treatment-naïve Patients With Chronic Lymphocytic Leukemia (CLL) (NCT04758975) | Paolo Ghia | 2022-09-19 |
| Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted (NCT05559164) | Rutgers, The State University of New Jersey | 2022-09-19 |
| ANC-501 in the Treatment of Adults With Major Depressive Disorder (NCT05439603) | Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc. | 2022-09-19 |
| Efficacy of Trimetazidine in Diabetic Patients (NCT05556005) | Ain Shams University | 2022-09-18 |
| Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer (NCT05529355) | Anhui Chest Hospital | 2022-09-18 |
| SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection. (NCT05461170) | Vir Biotechnology, Inc. | 2022-09-17 |
| Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm (NCT05538767) | Jennifer Keiser | 2022-09-16 |
| A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC (NCT05766410) | National Taiwan University Hospital | 2022-09-16 |
| Effect of Mesenchymal Stem Cells in Primary Knee Osteoarthritis (NCT05783154) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2022-09-16 |
| The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) (NCT05540327) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2022-09-16 |
| L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC (NCT05878028) | Quanli Gao | 2022-09-16 |
| Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma (NCT05268510) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2022-09-15 |
| SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC (NCT05652192) | Zhejiang Cancer Hospital | 2022-09-15 |
| Povidone Iodine Efficacy Study (NCT05272254) | University of Rochester | 2022-09-15 |
| Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) (NCT05520619) | Sun Yat-sen University | 2022-09-15 |
| A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease (NCT05476783) | TrueBinding, Inc. | 2022-09-15 |
| A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer (NCT05482568) | Jiangsu HengRui Medicine Co., Ltd. | 2022-09-15 |
| The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD (NCT05381974) | Massachusetts General Hospital | 2022-09-15 |
| Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults (NCT04989972) | Wake Network, Inc. | 2022-09-15 |
| Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis (NCT04880577) | Massachusetts General Hospital | 2022-09-15 |
| Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia (NCT05513976) | Jiangsu HengRui Medicine Co., Ltd. | 2022-09-15 |
| Arthritis Ease Study (NCT05721352) | Arizona State University | 2022-09-15 |
| A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH) (NCT05201144) | University of Utah | 2022-09-15 |
| Safety and Efficacy of RX-af01 Combined With PD-1 Antibody (NCT05576961) | Sun Yat-sen University | 2022-09-15 |
| Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) (NCT05466890) | Palatin Technologies, Inc | 2022-09-15 |
| Dapagliflozin With or Without Spironolactone for HFpEF (NCT05676684) | Universidade do Porto | 2022-09-15 |
| the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy (NCT05485558) | Tanta University | 2022-09-15 |
| The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke (NCT04789616) | University of Calgary | 2022-09-15 |
| Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression (NCT05512182) | Yonsei University | 2022-09-15 |
| Prophylaxis Against Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy (NCT06017167) | Tanta University | 2022-09-15 |
| Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer (NCT05551247) | First Affiliated Hospital Xi'an Jiaotong University | 2022-09-15 |
| Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study) (NCT05445934) | Frontier Biotechnologies Inc. | 2022-09-14 |
| Anti-malaria MAb in Kenyan Children (NCT05400655) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-09-14 |
| Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) (NCT05384821) | Centre Oscar Lambret | 2022-09-14 |
| Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors (NCT05729399) | Grit Biotechnology | 2022-09-14 |
| Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine (NCT05576623) | Cellid Co., Ltd. | 2022-09-14 |
| Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma (NCT05489887) | Giselle Sholler | 2022-09-14 |
| Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers (NCT05698212) | Hera Biotech, Inc. | 2022-09-14 |
| Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes. (NCT05368402) | Dompé Farmaceutici S.p.A | 2022-09-14 |
| PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NCT05465941) | Mayo Clinic | 2022-09-14 |
| A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (NCT05531565) | Biogen | 2022-09-13 |
| IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study) (NCT05401097) | Alice Mims | 2022-09-13 |
| Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer (NCT05251038) | Devalingam Mahalingam | 2022-09-13 |
| Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients (NCT05394857) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-09-13 |
| Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects (NCT05541939) | Vogenx, Inc. | 2022-09-13 |
| T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma (NCT05435014) | T-ACE Medical Co., Ltd | 2022-09-13 |
| Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma (NCT05512481) | Peking University Cancer Hospital & Institute | 2022-09-13 |
| A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer (NCT05492045) | InventisBio Co., Ltd | 2022-09-13 |
| A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF) (NCT05448391) | Aristea Therapeutics, Inc. | 2022-09-13 |
| Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer (NCT05383079) | Peter MacCallum Cancer Centre, Australia | 2022-09-13 |
| ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD) (NCT05081245) | MapLight Therapeutics | 2022-09-13 |
| Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC (NCT05536505) | Guangdong Association of Clinical Trials | 2022-09-13 |
| Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers (NCT05696067) | Tatyana Zubkova | 2022-09-13 |
| Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (NCT05467891) | Oana Danciu | 2022-09-13 |
| Reducing Pain From Wisdom Molar Extractions (NCT05335070) | Rutgers, The State University of New Jersey | 2022-09-13 |
| A Teleheath tDCS Approach to Decrease Cannabis Use (NCT05005013) | NYU Langone Health | 2022-09-13 |
| Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma (NCT04515459) | Institut Claudius Regaud | 2022-09-13 |
| Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis. (NCT05211986) | Immunis, Inc. | 2022-09-13 |
| Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma (NCT04933942) | European Organisation for Research and Treatment of Cancer - EORTC | 2022-09-13 |
| A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever (NCT05480800) | GlaxoSmithKline | 2022-09-13 |
| Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation. (NCT05370976) | University Hospital, Lille | 2022-09-13 |
| Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia (NCT05336812) | Ohio State University Comprehensive Cancer Center | 2022-09-13 |
| Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research (NCT05885776) | Tianjin Medical University Cancer Institute and Hospital | 2022-09-13 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (NCT05255601) | Bristol-Myers Squibb | 2022-09-13 |
| Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder (NCT05536414) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-09-12 |
| Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose (NCT05517668) | Richard Dart, MD, PhD | 2022-09-12 |
| Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults (NCT05465174) | Sabine Mueller, MD, PhD | 2022-09-12 |
| Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS) (NCT05308264) | Rigel Pharmaceuticals | 2022-09-12 |
| MoST-Influenced Behavioral Intervention for Walking (NCT05425641) | Northwell Health | 2022-09-12 |
| Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients (NCT05388435) | SK Life Science, Inc. | 2022-09-12 |
| Pharmacokinetics and Safety of DolutegravIr in Neonate (NCT05590325) | Desmond Tutu TB Centre | 2022-09-12 |
| Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT05485350) | Peking University Third Hospital | 2022-09-12 |
| Timely Intravenous Magnesium for Asthma in Children (NCT05166811) | University of Utah | 2022-09-12 |
| A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer (NCT05544136) | Memorial Sloan Kettering Cancer Center | 2022-09-12 |
| Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC (NCT05516589) | West China Hospital | 2022-09-12 |
| Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer (NCT05682950) | Peking Union Medical College Hospital | 2022-09-12 |
| A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas (NCT05566743) | Menoufia University | 2022-09-11 |
| Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma (NCT05528458) | Samsung Medical Center | 2022-09-11 |
| Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive) (NCT04591002) | Samsung Medical Center | 2022-09-11 |
| A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids (NCT05442827) | Jiangsu HengRui Medicine Co., Ltd. | 2022-09-10 |
| Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors (NCT05505877) | Shanghai Gopherwood Biotech Co., Ltd. | 2022-09-10 |
| Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer (NCT04728724) | Shanghai Pulmonary Hospital, Shanghai, China | 2022-09-10 |
| A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia (NCT05502367) | Antiva Biosciences | 2022-09-10 |
| Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer (NCT05531123) | Fudan University | 2022-09-10 |
| Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer (NCT05512780) | Hebei Medical University Fourth Hospital | 2022-09-10 |
| The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults (NCT05523089) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2022-09-09 |
| Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial (NCT05738681) | Mahidol University | 2022-09-09 |
| Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine (NCT05512949) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-09-09 |